Conference name: 2nd International conference
on pathology
Short name: Pathology 2019
Venue : Paris,France | July 5-6,2019
URL: https://bit.ly/2GS09CI
One reason why pancreatic cancer is so deadly is that the majority of patients often are identified late in their disease course and frequently present with inoperable tumors at the time of diagnosis. For some of these patients, it may be possible to shrink the tumor with existing chemotherapy drugs, but in a disease where 75 percent of patients die within a year of diagnosis, time is of the essence, and unfortunately, there's no way to know in advance which patients will respond to which drugs.
Author:James Ives
"Every pancreatic cancer is different, and performing molecular profiling of each patient's tumor could help determine the best treatment options," A one-size-fits-all approach isn't going to work. Therefore, we would like to make molecular profiling standard-of-care for patients with pancreatic cancer."Pancreatic cancer is a grim diagnosis, with a five-year survival rate of less than 9 percent
"Every pancreatic cancer is different, and performing molecular profiling of each patient's tumor could help determine the best treatment options," A one-size-fits-all approach isn't going to work. Therefore, we would like to make molecular profiling standard-of-care for patients with pancreatic cancer."Pancreatic cancer is a grim diagnosis, with a five-year survival rate of less than 9 percent
To know more about Pathology and its Applications do attend
International Conference on Pathology 2019 http://pathology.alliedacademies.com/
Contact
KRISTIE NOVA
Program Director | PATHOLOGY 2019
Phone: (44) 20 3769 1755
Email: pathology(at)alliedannualsummit(dot)com
KRISTIE NOVA
Program Director | PATHOLOGY 2019
Phone: (44) 20 3769 1755
Email: pathology(at)alliedannualsummit(dot)com
No comments:
Post a Comment